المؤلفون: Wang M; Department of Lymphoma/Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX., Robak T; Department of Hematology, Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland., Maddocks KJ; Division of Hematology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Phillips T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI., Smith SD; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA., Gallinson D; Summit Medical Group, Florham Park, NJ., Calvo R; AstraZeneca, Gaithersburg, MD., Wun CC; AstraZeneca, South San Francisco, CA., Munugalavadla V; AstraZeneca, South San Francisco, CA., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.

المصدر: Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4539-4548.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/drug therapy , Rituximab*/therapeutic use , Rituximab*/administration & dosage , Rituximab*/adverse effects , Sulfonamides*/therapeutic use , Sulfonamides*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Pyrazines*/administration & dosage , Pyrazines*/therapeutic use , Pyrazines*/adverse effects , Benzamides*/therapeutic use , Benzamides*/administration & dosage , Benzamides*/adverse effects, Humans ; Middle Aged ; Male ; Aged ; Female ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Bridged Bicyclo Compounds, Heterocyclic/administration & dosage ; Bridged Bicyclo Compounds, Heterocyclic/adverse effects ; Aged, 80 and over ; Adult ; Treatment Outcome ; COVID-19/mortality ; SARS-CoV-2

المؤلفون: Xu Y; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210046, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Ren Y; State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China., Zhang J; State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China., Niu B; State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China., Liu M; State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China., Xu T; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Zhang X; State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China., Shen J; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210046, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Wang K; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. Electronic address: kwang@simm.ac.cn., Cao Z; State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China. Electronic address: zcao@cpu.edu.cn.

المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 Sep 05; Vol. 275, pp. 116565. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Pyrazines*/chemistry , Pyrazines*/pharmacology , Pyrazines*/chemical synthesis , TRPC Cation Channels*/antagonists & inhibitors , TRPC Cation Channels*/metabolism , Hypertension*/drug therapy, Animals ; Humans ; Rats ; HEK293 Cells ; Structure-Activity Relationship ; Male ; Drug Discovery ; Molecular Structure ; Pyridazines/pharmacology ; Pyridazines/chemistry ; Pyridazines/chemical synthesis ; Dose-Response Relationship, Drug ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/chemistry ; Antihypertensive Agents/chemical synthesis ; Rats, Sprague-Dawley ; Imidazoles/chemistry ; Imidazoles/pharmacology ; Imidazoles/chemical synthesis

المؤلفون: Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Jones D; The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Department of Pathology, The Ohio State University, Columbus, OH., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Robak T; Medical University of Lodz, and Copernicus Memorial Hospital, Lodz, Poland., Illés Á; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Kater AP; Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, on behalf of HOVON, Amsterdam, The Netherlands., Ghia P; Università Vita-Salute San Raffaele, Milan, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Byrd JC; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH., Seymour JF; Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia., Long S; The Ohio State University Wexner Medical Center James Molecular Laboratory, Columbus, OH., Mohamed N; Department of Pathology, The Ohio State University, Columbus, OH., Benrashid S; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Lai TH; The Ohio State University Comprehensive Cancer Center, Columbus, OH., De Jesus G; AstraZeneca, South San Francisco, CA., Lai R; AstraZeneca, South San Francisco, CA., de Bruin G; Acerta Pharma BV, a member of the AstraZeneca group, Oss, The Netherlands., Rule S; AstraZeneca, Mississauga, ON, Canada., Munugalavadla V; AstraZeneca, South San Francisco, CA.

المصدر: Blood [Blood] 2024 Sep 05; Vol. 144 (10), pp. 1061-1068.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Adenine*/analogs & derivatives , Agammaglobulinaemia Tyrosine Kinase*/genetics , Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Benzamides*/therapeutic use , Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , Mutation* , Piperidines*/therapeutic use , Pyrazines*/therapeutic use , Pyrazines*/administration & dosage , Pyrazoles*/therapeutic use , Pyrimidines*/therapeutic use , Pyrimidines*/administration & dosage, Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Disease Progression ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/administration & dosage

المؤلفون: Burger CD; Division of Pulmonary, Allergy and Sleep Medicine, Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida., Tang W; Actelion Pharmaceuticals US, Inc, a Johnson & Johnson Company, Titusville, New Jersey., Tsang Y; Actelion Pharmaceuticals US, Inc, a Johnson & Johnson Company, Titusville, New Jersey., Panjabi S; Actelion Pharmaceuticals US, Inc, a Johnson & Johnson Company, Titusville, New Jersey.

المصدر: JAMA network open [JAMA Netw Open] 2024 Sep 03; Vol. 7 (9), pp. e2434691. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Acetamides*/therapeutic use , Acetamides*/administration & dosage , Pyrazines*/therapeutic use , Pyrazines*/administration & dosage , Phosphodiesterase 5 Inhibitors*/therapeutic use , Phosphodiesterase 5 Inhibitors*/administration & dosage , Drug Therapy, Combination*, Humans ; Female ; Male ; Middle Aged ; Adult ; Pulmonary Arterial Hypertension/drug therapy ; Endothelin Receptor Antagonists/therapeutic use ; Endothelin Receptor Antagonists/administration & dosage ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/administration & dosage ; Treatment Outcome ; Aged

المؤلفون: Fang L; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Engineering Technology Research Center of Modernized Pharmaceutics, Anhui Education Department (AUCM), Hefei 230012, Anhui, China.; Institute of Pharmacokinetics, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Anhui Genuine Chinese Medicinal Materials Quality Improvement Collaborative Innovation Center, Hefei 230012, Anhui, China.; Anhui Academy of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, P.R. China., Cheng H; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Engineering Technology Research Center of Modernized Pharmaceutics, Anhui Education Department (AUCM), Hefei 230012, Anhui, China.; Institute of Pharmacokinetics, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Anhui Genuine Chinese Medicinal Materials Quality Improvement Collaborative Innovation Center, Hefei 230012, Anhui, China.; Anhui Academy of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, P.R. China., Chen W; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Engineering Technology Research Center of Modernized Pharmaceutics, Anhui Education Department (AUCM), Hefei 230012, Anhui, China.; Institute of Pharmacokinetics, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Anhui Genuine Chinese Medicinal Materials Quality Improvement Collaborative Innovation Center, Hefei 230012, Anhui, China.; Anhui Academy of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, P.R. China., Peng C; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Engineering Technology Research Center of Modernized Pharmaceutics, Anhui Education Department (AUCM), Hefei 230012, Anhui, China.; Institute of Pharmacokinetics, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Anhui Genuine Chinese Medicinal Materials Quality Improvement Collaborative Innovation Center, Hefei 230012, Anhui, China.; Anhui Academy of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, P.R. China., Liu Y; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Engineering Technology Research Center of Modernized Pharmaceutics, Anhui Education Department (AUCM), Hefei 230012, Anhui, China.; Institute of Pharmacokinetics, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Anhui Genuine Chinese Medicinal Materials Quality Improvement Collaborative Innovation Center, Hefei 230012, Anhui, China.; Anhui Academy of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, P.R. China., Zhang C; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Engineering Technology Research Center of Modernized Pharmaceutics, Anhui Education Department (AUCM), Hefei 230012, Anhui, China.; Institute of Pharmacokinetics, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China.; Anhui Genuine Chinese Medicinal Materials Quality Improvement Collaborative Innovation Center, Hefei 230012, Anhui, China.; Anhui Academy of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, P.R. China.

المصدر: The Journal of pharmacy and pharmacology [J Pharm Pharmacol] 2024 Sep 03; Vol. 76 (9), pp. 1169-1177.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0376363 Publication Model: Print Cited Medium: Internet ISSN: 2042-7158 (Electronic) Linking ISSN: 00223573 NLM ISO Abbreviation: J Pharm Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Alzheimer Disease*/drug therapy , Alzheimer Disease*/metabolism , Abietanes*/pharmacology , Pyrazines*/pharmacology , Pyrazines*/therapeutic use , Disease Models, Animal* , Cognitive Dysfunction*/drug therapy , Oxidative Stress*/drug effects , Apoptosis*/drug effects , Rats, Sprague-Dawley* , Emulsions* , Neurons*/drug effects , Neurons*/metabolism, Animals ; Male ; Rats ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Caspase 3/metabolism ; Nanoparticles ; bcl-2-Associated X Protein/metabolism

المؤلفون: Lange TJ; Department of Pulmonology, Kreisklinik Bad Reichenhall, Riedelstraße 5, 83435, Bad Reichenhall, Germany. Tobias.Lange@kliniken-sob.de.; Faculty of Medicine, Department Internal Medicine II, Regensburg University, Regensburg, Germany. Tobias.Lange@kliniken-sob.de., Escribano-Subias P; Pulmonary Hypertension Unit, Cardiology Department, CIBERCV, Hospital 12 de Octubre, Madrid, Spain., Muller A; Global Epidemiology, Actelion Pharmaceuticals Ltd, a Johnson & Johnson Company, Allschwil, Switzerland., Fernandes CC; Global Medical Affairs, Actelion Pharmaceuticals Ltd, a Johnson & Johnson Company, Allschwil, Switzerland., Fontana M; Statistics and Decision Sciences, Janssen-Cilag S.p.A, a Johnson & Johnson Company, Milan, Italy., Remenova T; Global Medical Safety, Actelion Pharmaceuticals Ltd, a Johnson & Johnson Company, Allschwil, Switzerland., Söderberg S; Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden., Gaine S; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.

المصدر: Advances in therapy [Adv Ther] 2024 Sep; Vol. 41 (9), pp. 3645-3663. Date of Electronic Publication: 2024 Jul 31.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

مواضيع طبية MeSH: Acetamides*/therapeutic use , Pyrazines*/therapeutic use , Pyrazines*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Risk Assessment/methods ; Aged ; Prospective Studies ; Pulmonary Arterial Hypertension/drug therapy ; Adult ; Antihypertensive Agents/therapeutic use

المؤلفون: Dong L; College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Zhang H; College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Zhang G; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Li F; College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Li M; College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Wang H; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Ye X; College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Ren X; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China., Zhang J; College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China., Peng C; College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China. Electronic address: pengcan@ahtcm.edu.cn., Liu H; Jiangsu University, Zhenjiang 212000, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China; Jiangsu Yunshi Pharmaceutical Technology Co.Ltd., Nantong 226133, China. Electronic address: liuhongfei@ujs.edu.cn., Wu L; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China; Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China. Electronic address: wuli@simm.ac.cn.

المصدر: Journal of pharmaceutical sciences [J Pharm Sci] 2024 Sep; Vol. 113 (9), pp. 2786-2794. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE

مواضيع طبية MeSH: Pyrazines*/pharmacokinetics , Pyrazines*/administration & dosage , Pyrazines*/chemistry , Delayed-Action Preparations*/pharmacokinetics , Biological Availability* , Polystyrenes*/chemistry , Polystyrenes*/pharmacokinetics , Drug Carriers*/chemistry, Animals ; Rabbits ; Humans ; Ophthalmic Solutions/pharmacokinetics ; Ophthalmic Solutions/administration & dosage ; Swine ; Male ; Administration, Ophthalmic ; Drug Delivery Systems/methods ; Drug Liberation ; Cornea/metabolism ; Cornea/drug effects

المؤلفون: Kaya K; Department of Medical Biochemistry, Faculty of Medicine, Pamukkale University, Denizli, Türkiye., Şahin Y; Department of Medical Pharmacology, Faculty of Medicine, Pamukkale University, Denizli, Türkiye., Demirel HH; Bayat Laborant & Veterinary Health Division, Afyon Kocatepe University, Afyon, Türkiye., Çiftçi O; Department of Medical Pharmacology, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.

المصدر: Drug and chemical toxicology [Drug Chem Toxicol] 2024 Sep; Vol. 47 (5), pp. 640-648. Date of Electronic Publication: 2023 Jul 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Group Country of Publication: United States NLM ID: 7801723 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6014 (Electronic) Linking ISSN: 01480545 NLM ISO Abbreviation: Drug Chem Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Pyrazines*/pharmacology , Pyrazines*/administration & dosage , Amides*/pharmacology , Ascorbic Acid*/pharmacology , Ascorbic Acid*/administration & dosage , Apoptosis*/drug effects , Brain*/drug effects , Brain*/metabolism , Brain*/pathology , Antiviral Agents*/pharmacology , Antiviral Agents*/toxicity , Antiviral Agents*/administration & dosage , Oxidative Stress*/drug effects, Animals ; Rats ; Male ; Rats, Wistar ; Antioxidants/pharmacology ; Antioxidants/administration & dosage ; Dose-Response Relationship, Drug ; COVID-19 Drug Treatment ; Aging/drug effects

المؤلفون: Cheng X; College of Agriculture, Henan University of Science and Technology, Luoyang, China., Liu F; College of Agriculture, Henan University of Science and Technology, Luoyang, China., Liu X; College of Agriculture, Henan University of Science and Technology, Luoyang, China., Yang X; College of Agriculture, Henan University of Science and Technology, Luoyang, China.

المصدر: Journal of the science of food and agriculture [J Sci Food Agric] 2024 Sep; Vol. 104 (12), pp. 7109-7117. Date of Electronic Publication: 2024 Apr 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 0376334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0010 (Electronic) Linking ISSN: 00225142 NLM ISO Abbreviation: J Sci Food Agric Subsets: MEDLINE

مواضيع طبية MeSH: Vitis*/chemistry , Vitis*/metabolism , Wine*/analysis , Abscisic Acid*/metabolism , Odorants*/analysis , Fruit*/chemistry , Fruit*/metabolism , Pyrazines*/analysis , Pyrazines*/metabolism, Humans ; Plant Proteins/metabolism ; Plant Proteins/genetics ; Flavoring Agents/chemistry ; Flavoring Agents/metabolism ; Plant Growth Regulators/pharmacology

المؤلفون: Westover JB; Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA., Bailey KW; Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA., Wasson SR; Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA., Boardman KM; Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA., Lustig KH; Kineta, Inc., Seattle, WA, USA., Amberg SM; Kineta, Inc., Seattle, WA, USA., Gowen BB; Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA. Electronic address: brian.gowen@usu.edu.

المصدر: Antiviral research [Antiviral Res] 2024 Sep; Vol. 229, pp. 105952. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE

مواضيع طبية MeSH: Pyrazines*/pharmacology , Pyrazines*/administration & dosage , Pyrazines*/therapeutic use , Amides*/pharmacology , Amides*/therapeutic use , Amides*/administration & dosage , Junin virus*/drug effects , Antiviral Agents*/pharmacology , Antiviral Agents*/administration & dosage , Antiviral Agents*/therapeutic use , Disease Models, Animal*, Animals ; Guinea Pigs ; Hemorrhagic Fever, American/drug therapy ; Hemorrhagic Fever, American/virology ; Drug Therapy, Combination ; Female ; Drug Synergism ; Arenaviridae Infections/drug therapy